Hydroxychloroquine questions intensify as journal says its drug study "did not meet expected standards"
Shortly after publication, scientists ...began to point out flaws in the research that cast doubt on the study. On March 24, Bik published a long list. https://t.co/rrJ5GpZQKU

— Elisabeth Bik (@MicrobiomDigest) April 7, 2020